JANX vs SCHW · rev $10.3M vs P/E 19, rev $13.55B
Janux Therapeutics Inc (JANX) versus Charles Schwab Corp (SCHW) — a side-by-side from cached financials, not a winner call.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Richard Andrew Wurster C.F.A., CMT.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
Latest reported SCHW revenue for 2026-06-30 was $13.55B. Net income was $5.28B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
JANX currently screens at market cap $1.49B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Not investment advice. Open the JANX and SCHW stock pages for the full models.
Not investment advice.